Find the funding your business is owed
GrantHub tracks 1,902+ active grants, tax credits, and funding programs across 21 countries. Filter by your country and industry to uncover government schemes, foundation funding, and corporate grants your business can apply for — verified and updated weekly.
Grants in Europe
Call for proposals to support projects that aim to drive the integration of New Approach Methodologies (NAMs) across the biomedical and chemical safety spectrum.
European Union
Call for proposals to support projects that aim to drive the integration of New Approach Methodologies (NAMs) across the biomedical and chemical safety spectrum. With a total budget of EUR 49.00 million, the call provides grants between EUR 5.00 and 8.00 million to support projects that reduce reliance on animal testing while enhancing the human relevance of drug discovery and regulatory assessments. Proposals should focus on developing or optimizing scalable, reproducible platforms that utilize cutting-edge technologies. These include: Complex In-Vitro Models: Utilizing induced Pluripotent Stem Cells (iPSC), patient-derived organoids, and sophisticated Organ-on-Chip (OoC) systems; Digital Innovation: Incorporating AI-driven predictive modeling and Virtual Twin technology to simulate disease progression and intervention responses; and Real-time Monitoring: Integrating embedded sensors to capture immediate physiological responses.
Call for proposals to establish a coordinated network of Centres of Excellence (CoEs) for Advanced Therapy Medicinal Products (ATMPs).
European Union
Call for proposals to establish a coordinated network of Centres of Excellence (CoEs) for Advanced Therapy Medicinal Products (ATMPs). With a total budget of EUR 3.90 million, this call seeks to consolidate Europe's scattered innovation hubs into a world-class ecosystem capable of competing globally in the development of gene therapies, cell therapies, and tissue-engineered products. The initiative aims to bridge the gap from laboratory discovery to patient delivery by supporting existing centres embedded within vibrant bioclusters. Selected CoEs must already possess critical infrastructure, including state-of-the-art Good Manufacturing Practice (GMP) facilities and clinical trial capabilities. The network is intended to be limited to a maximum of 10 centres across the EU, each offering complementary expertise to ensure comprehensive coverage of various ATMP technologies. Proposed projects, spanning the period of 2027–2030, must address the following mandates: Policy and Harmonization: Develop recommendations for clinical trials, logistics, and the harmonization of market access and reimbursement procedures; Long-term Vision: Create a roadmap with clear milestones to position Europe as a global leader in ATMP research and innovation by 2035; Stakeholder Engagement: Establish a diverse advisory board and foster a multi-sectoral consortium including regulators, industry actors, and patient organizations; and Education: Design training programs for the next generation of scientists and conduct outreach to improve public understanding of advanced therapies.
Call for proposals to address the significant sex and gender disparities in cardiovascular diseases (CVDs), which accounted for over 1.
European Union
Call for proposals to address the significant sex and gender disparities in cardiovascular diseases (CVDs), which accounted for over 1.7 million deaths (32% of all deaths) in the EU in 2021. With a total budget of EUR 39.30 million, the call offers individual awards between EUR 6.00 and 7.00 million to support projects that translate basic biological discoveries into innovative prevention, diagnosis, and treatment strategies tailored to specific physiological and sociocultural needs. Proposals are expected to further the understanding of structural, hormonal, and biological distinctions between sexes. Key focus areas include: Tailored Risk Models: Developing sex-specific models for better disease detection and prevention; Determinant Identification: Validating health determinants by integrating data from disciplines like molecular biology, genetics, and social epidemiology; Data Integration: Utilizing existing health registries, cohorts, and biobanks while ensuring any new data adheres to FAIR principles; and Technological Innovation: Encouraging the use of advanced tools, including Generative AI, to support research outcomes.
Call for proposals to support projects that aim at mitigating the long-term health and economic impacts of persistent conditions resulting from microbial infections (excluding cancer).
European Union
Call for proposals to support projects that aim at mitigating the long-term health and economic impacts of persistent conditions resulting from microbial infections (excluding cancer). With a total budget of EUR 39.30 million, this initiative seeks to award individual grants between EUR 6.00 and 8.00 million to projects that improve the prevention, diagnosis, and management of these often underdiagnosed conditions. Proposals should adopt a multidisciplinary approach to identify risk and protective factors—such as genetics and inflammatory responses—and increase our understanding of disease pathophysiology. Key research areas include: Developing clinically validated diagnostic tools and biomarkers; Conducting early-stage clinical trials for preventive or therapeutic interventions; Identifying effective rehabilitation strategies, including physical and cognitive therapies; and Integrating disease management into primary and specialized healthcare settings.
Call for proposals to support projects that to address the significant challenge of low-value care, which is estimated to account for up to one-fifth of global healthcare spending.
European Union
Call for proposals to support projects that to address the significant challenge of low-value care, which is estimated to account for up to one-fifth of global healthcare spending. With a total budget of €38 million and individual awards expected around €10 million, the initiative seeks to develop evidence-based methodologies to identify, measure, and reduce wasteful medical practices. By reallocating these resources, the program aims to maximize health outcomes, improve the resilience of care systems, and reduce the environmental footprint of healthcare delivery. Selected projects must adopt a patient-centered, multidisciplinary approach to achieve the following: Identification and Measurement: Develop a deep understanding of how to detect low-value care throughout the healthcare process, including testing specific indicators for overuse, misuse, and unwarranted variation; Innovative Strategies: Pilot and scale effective strategies for reducing low-value care across diverse European settings, ensuring these solutions are transferable across different healthcare systems; Systems Analysis: Examine healthcare payment and financing models to determine if they unintentionally incentivize low-value care and evaluate alternative models that align with high-value patient outcomes; and Technological Integration: Utilize data models, digital tools, and artificial intelligence to identify inefficiencies and facilitate collaboration between international health registries and databases.
Call for proposals to conduct a comprehensive review of cardiovascular research and innovative healthcare solutions at national, EU, and international levels.
European Union
Call for proposals to conduct a comprehensive review of cardiovascular research and innovative healthcare solutions at national, EU, and international levels. With a total funding allocation of €1.90 million, this initiative aims to identify critical gaps in the field and establish a Strategic Research and Innovation Agenda (SRIA) to improve risk prediction, early detection, and screening for cardiovascular diseases (CVDs) and associated comorbidities like obesity and diabetes. Cardiovascular diseases currently represent the leading cause of death in the EU, accounting for over 1.7 million deaths annually and consuming approximately 11% of healthcare budgets, totaling €282 billion. The proposal is designed to support the upcoming EU Cardiovascular Health plan by integrating digital tools, Virtual Human Twins (VHT), and AI-driven methods. Key activities include: Gap Analysis and Mapping: Conducting a global review of research and innovation, with specific emphasis on addressing sex- and gender-related gaps in diagnosis and treatment; Overcoming Barriers: Generating a detailed report on the obstacles to personalized prevention and providing evidence-based recommendations to bypass these challenges; Inclusive Research Design: Integrating variables such as age, genetic predisposition, lifestyle, and racial or ethnic origin into data analysis to ensure findings are generalizable across diverse populations; Stakeholder Collaboration: Organizing multi-sectoral events to align healthcare providers, researchers, and policymakers, while involving Social Sciences and Humanities (SSH) experts to enhance societal impact.
Frequently asked questions
GrantHub is an informational directory. Grant eligibility, amounts, and deadlines are subject to change. Always verify details on the official funding body's website before applying. GrantHub does not guarantee eligibility or funding outcomes.